We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$3.38B
AUM Growth
+$357M
Cap. Flow
+$11.3M
Cap. Flow %
0.33%
Top 10 Hldgs %
28.56%
Holding
841
New
147
Increased
207
Reduced
242
Closed
138

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$62.8M
2
MUNI icon
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
+$41M
3
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$22.2M
4
TFI icon
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
+$17.5M
5
IBTG icon
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
+$13M

Top Sells

Rank Stock Value
1
PDBC icon
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
+$61.4M
2
CMF icon
iShares California Muni Bond ETF
CMF
+$37.9M
3
IBTE
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
+$29.8M
4
MUB icon
iShares National Muni Bond ETF
MUB
+$12.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$8.52M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Healthcare 8.75%
3 Financials 6.76%
4 Consumer Discretionary 4.63%
5 Communication Services 4.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAUR icon
676
Laureate Education
LAUR
$5.18B
$143K ﹤0.01%
10,400
-6,800
-40% -$93.3K
UUUU icon
677
Energy Fuels
UUUU
$2.82B
$141K ﹤0.01%
19,643
-12,857
-40% -$99.5K
PDBC icon
678
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$5.81B
$137K ﹤0.01%
10,294
-4,285,485
-100% -$61.4M
PLX icon
679
Protalix BioTherapeutics
PLX
$192M
$121K ﹤0.01%
+68,100
New +$106K
VIA
680
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$118K ﹤0.01%
+12,565
New +$98.8K
YMAB
681
DELISTED
Y-mAbs Therapeutics
YMAB
$115K ﹤0.01%
+16,900
New +$97.7K
ESOA icon
682
Energy Services of America
ESOA
$297M
$112K ﹤0.01%
+18,800
New +$86K
MNKD icon
683
MannKind Corp
MNKD
$1.28B
$112K ﹤0.01%
+30,800
New +$118K
VNDA icon
684
Vanda Pharmaceuticals
VNDA
$311M
$111K ﹤0.01%
+26,300
New +$106K
ADMA icon
685
ADMA Biologics
ADMA
$1.92B
$110K ﹤0.01%
+24,400
New +$90.3K
CGEM icon
686
Cullinan Oncology
CGEM
$1.05B
$110K ﹤0.01%
+10,800
New +$95.7K
LICY
687
DELISTED
Li-Cycle Holdings Corp.
LICY
$110K ﹤0.01%
23,413
-1,041
-4% -$11.8K
TNYA icon
688
Tenaya Therapeutics
TNYA
$168M
$107K ﹤0.01%
+32,900
New +$71K
ERAS icon
689
Erasca
ERAS
$6.64B
$107K ﹤0.01%
+50,000
New +$105K
NKTX icon
690
Nkarta
NKTX
$161M
$106K ﹤0.01%
+16,113
New +$41.7K
HBIO icon
691
Harvard Bioscience
HBIO
$27.2M
$106K ﹤0.01%
+1,972
New +$89K
VMEO
692
DELISTED
Vimeo
VMEO
$105K ﹤0.01%
+26,800
New +$95.7K
IOVA icon
693
Iovance Biotherapeutics
IOVA
$2.22B
$103K ﹤0.01%
+12,700
New +$66.5K
ETON icon
694
Eton Pharmaceutcials
ETON
$1.17B
$99.2K ﹤0.01%
+22,639
New +$90.8K
BTMD icon
695
Biote Corp
BTMD
$68.9M
$96.3K ﹤0.01%
+19,500
New +$101K
NHS
696
Neuberger High Yield Strategies Fund Inc
NHS
$251M
$83.7K ﹤0.01%
10,839
– –
SGMA
697
DELISTED
Sigmatron International
SGMA
$63.8K ﹤0.01%
+21,275
New +$66.8K
DFTX
698
Definium Therapeutics
DFTX
$5.73B
$63.3K ﹤0.01%
+17,300
New +$52.1K
OPTT icon
699
Ocean Power Technologies
OPTT
$38.5M
$62.2K ﹤0.01%
196,839
-43,510
-18% -$14.4K
UROY
700
Uranium Royalty Corp
UROY
$434M
$55.4K ﹤0.01%
+20,500
New +$57.4K
26 27
28
29 30

Similar funds

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
NHC
Nicholas Hoffman & Company Atlanta, Georgia $4.33B AUM 18.98% 1-Year Est. Return
EQF
Evergreen Quality Fund Grand Cayman, Cayman Islands $4.37B AUM 119.42% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return

Bailard's Q4 2023 Portfolio in Review

As of Q4 2023, Bailard held 841 positions worth $3.38B, up 12% from $3.02B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bailard's Q4 2023 filing shows 147 new, 207 increased, 242 reduced and 138 closed positions. Its largest new stake was Vanguard Tax-Exempt Bond Index Fund: 452,690 shares worth $23.1M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $61.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q4 2023 buy was Vanguard Tax-Exempt Bond Index Fund: 452,690 shares worth $23.1M.
  • Bailard added most to SPDR Gold Trust in Q4 2023, an estimated $62.8M increase.
  • Bailard's biggest Q4 2023 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $61.4M.
  • Bailard fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $5.5M.
  • Bailard's ten largest holdings make up 29% of its $3.38B portfolio in Q4 2023.
  • Bailard opened 147 new positions and closed 138 in Q4 2023.
  • Bailard's portfolio value rose 12% quarter-over-quarter to $3.38B.

Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.